Novo Nordisk shares rose Monday as the company said it would present new data on the ability of semaglutide, the active ingredient in its weight-loss drugs Ozempic and Wegovy, to lower heart risks.

Does ‘Nature’s Ozempic’ exist? Experts say it's complicated. While some supplements could cause a small amount of weight loss ...

GLP-1 drugs such as Wegovy, Ozempic, Zepbound and Mounjaro have helped millions of people combat type 2 diabetes and ...

They’re expensive and aren’t a short-term fix, but Ozempic and Wegovy show great promise in regulating weight. | Opinion ...

The exorbitant costs of drugs like Wegovy — especially compared to other countries — have prompted some insurers to tighten ...

Needless to say, because this is an experimental and unauthorized approach, there are no microdosing guidelines. There is also no reliable information about the safety of this practice, or the ...

While appearing on the March 13 episode of Grindr's Who's the A------ podcast, the Hacks star, 34, spoke about a host of ...

Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat alcohol use disorder and alcohol-associated liver disease.

Weight loss drugs like Ozempic deliver more health benefits than expected.

Blockbuster GLP-1 medications are changing patient care, impacting surgery volumes and reshaping the financial landscape of the healthcare industry.

With semaglutide shortages in the rearview, Novo Nordisk is doubling down on marketing efforts for its GLP-1 drugs.

LSU Health Shreveport has announced the Rapides Health Project, which works by providing a free three-month supply of GLP-1 agonists. You may know these by other names, such as Semaglutide, Mounjaro ...